4-aminopyridine has been researched along with Behavior Disorders in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severity of 6-OHDA-induced Parkinsonism was assessed by conventional behavioural tests." | 1.43 | Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation. ( Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Mahmudi, M; Piri, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haghdoost-Yazdi, H | 1 |
| Piri, H | 1 |
| Faraji, A | 1 |
| Fraidouni, N | 1 |
| Dargahi, T | 1 |
| Mahmudi, M | 1 |
| Alipour Heidari, M | 1 |
1 other study available for 4-aminopyridine and Behavior Disorders
| Article | Year |
|---|---|
Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
Topics: 4-Aminopyridine; Adrenergic Agents; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; D | 2016 |